long-term follow-up patient recurr malign glioma adjuv adopt immunotherapi between august octob denver brain tumor research group clinic trial autolog human recombin lymphocyt patient recurr high-grad glioma trial involv surgic resect and/or decompress intracavitari implant lymphokine-activ killer lak cell autolog lymphocyt asl plasma clot month lymphocyt rickham reservoir cathet tumor bed lak cell peripher blood lymphocyt day asl lectin- peripher blood lymphocyt day patient group mean age year rang year karnofski rate rang mean decadron dose entri mg/d rang averag number lymphocyt rang date patient recurr tumor growth median overal surviv time week rang median surviv time immunotherapi week rang signific differ surviv immunotherapi patient previou chemotherapi use steroid prior chemotherapi vitro gener asl lak cell 